瑞华泰连亏两年半 2021年上市两募资共6.99亿

Core Viewpoint - 瑞华泰 (688323.SH) reported a significant increase in revenue for the first half of 2025, but continued to face net losses, indicating ongoing challenges despite revenue growth [1][2]. Financial Performance - The company achieved operating revenue of 181.93 million yuan in the first half of 2025, representing a year-on-year increase of 37.86% [1][2]. - The net profit attributable to shareholders was -33.73 million yuan, an improvement from -36.13 million yuan in the same period last year [1][2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -34.08 million yuan, compared to -36.78 million yuan in the previous year [1][2]. - The net cash flow from operating activities was 93.86 million yuan, showing a substantial increase of 164.65% year-on-year [1][2]. Historical Financial Data - In 2024, the company reported operating revenue of 339.05 million yuan, a year-on-year increase of 22.88% [3]. - The net profit attributable to shareholders for 2024 was -57.27 million yuan, worsening from -19.60 million yuan in 2023 [3]. - The net cash flow from operating activities in 2024 was 137.52 million yuan, reflecting a growth of 125.20% compared to the previous year [3]. Fundraising Activities - The total amount raised from the company's initial public offering (IPO) was 268.65 million yuan, with a net amount of 218.32 million yuan after expenses [4]. - The company initially planned to raise 400 million yuan for a high-performance polyimide film project, but the final net amount raised was 182 million yuan less than planned [4]. - The company issued convertible bonds in 2022, raising a total of 430 million yuan, with the proceeds deposited into a designated account [4][5].